DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway

References

• Craig AJ, Felden JV, Garcia-Lezana T, et al. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17(3):139–152.
   PubMed Web of Science ®Google Scholar
• Raoul JL, Edeline J. Systemic treatment of hepatocellular carcinoma: standard of care in China and elsewhere. Lancet Oncol. 2020;21(4):479–481.
   PubMed Web of Science ®Google Scholar
• Chan L-K, Ng IO-L. Joining the dots for better liver cancer treatment. Nat Rev Gastroenterol Hepatol. 2020;17(2):74–75.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Yang SL, Luo YY, Chen M, et al. A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy. HPB. 2017;19(10):835–842.
   PubMed Web of Science ®Google Scholar
• Ryu SH, Jang MK, Kim WJ, et al. Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine. Cancer Metastasis Rev. 2014;33(4):965–980.
   PubMed Web of Science ®Google Scholar
• Abdelhaleem M, Maltais L, Wain H. The human DDX and DHX gene families of putative RNA helicases. Genomics. 2003;81(6):618–622.
   PubMed Web of Science ®Google Scholar
• Fuller-Pace FV. DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res. 2006;34(15):4206–4215.
   PubMed Web of Science ®Google Scholar
• Lin H, Liu W, Fang Z, et al. Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer. Sci Rep. 2015;5:9247.
   PubMed Web of Science ®Google Scholar
• Huang C, Liang X, Huang R, et al. Up-regulation and clinical relevance of novel helicase homologue DHX32 in colorectal cancer. J Exp Clin Cancer Res: CR. 2009;28:11.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhang G, Wang Y, et al. DHX32 expression is an indicator of poor breast cancer prognosis. Oncol Lett. 2017;13(2):942–948.
   PubMed Web of Science ®Google Scholar
• Pant D, Narayanan SP, Vijay N, et al. Hypoxia-induced changes in intragenic DNA methylation correlate with alternative splicing in breast cancer. J Biosci. 2020;45:3.
   PubMed Web of Science ®Google Scholar
• Lin H, Fang Z, Su Y, et al. DHX32 promotes angiogenesis in colorectal cancer through augmenting β-catenin signaling to induce expression of VEGFA. EBioMedicine. 2017;18:62–72.
   PubMed Web of Science ®Google Scholar
• Giannelli G, Koudelkova P, Dituri F, et al. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65(4):798–808.
   PubMed Web of Science ®Google Scholar
• Abdelhaleem M. The novel helicase homologue DDX32 is down-regulated in acute lymphoblastic leukemia. Leuk Res. 2002;26(10):945–954.
   PubMed Web of Science ®Google Scholar
• Wang W, Smits R, Hao H, et al. Wnt/β-Catenin Signaling in Liver Cancers. Cancers. 2019;11(7):926.
   PubMed Web of Science ®Google Scholar
• Perugorria MJ, Olaizola P, Labiano I, et al. Wnt-β-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(2):121–136.
   PubMed Web of Science ®Google Scholar
• Liu L-J, Xie S-X, Chen Y-T, et al. Aberrant regulation of Wnt signaling in hepatocellular carcinoma. World J Gastroenterol. 2016;22(33):7486–7499.
   PubMed Web of Science ®Google Scholar
• Ma L, Lin K, Chang G, et al. Aberrant activation of β-catenin signaling drives glioma tumorigenesis via USP1-mediated stabilization of EZH2. Cancer Res. 2019;79(1):72–85.
   PubMed Web of Science ®Google Scholar
• Gao F, Alwhaibi A, Sabbineni H, et al. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis. Cancer Lett. 2017;402:177–189.
   PubMed Web of Science ®Google Scholar
• Luo Y, Jian-Jun J-J, Lv Q, et al. Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/β-catenin signaling pathway. Cancer Lett. 2019;440–441:11–22.
   PubMed Web of Science ®Google Scholar
• Kim K, Lisby A, Ma C, et al. Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nat Commun. 2019;10(1):1909.
   PubMed Web of Science ®Google Scholar
• Chen L, Mai W, Chen M, et al. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin. Pharmacol Res. 2017;123:130–142.
   PubMed Web of Science ®Google Scholar
• Dimri M, Satyanarayana A. Molecular signaling pathways and therapeutic targets in hepatocellular carcinoma. Cancers. 2020;12(2):491.
   PubMed Web of Science ®Google Scholar
• Patel S, Alam A, Pant R, et al. Wnt signaling and its significance within the tumor microenvironment: novel therapeutic insights. Front Immunol. 2019;10:2872.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye X, Zhang J-B, et al. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation. Oncogene. 2015;34(44):5524–5535.
   PubMed Web of Science ®Google Scholar
• Xiang D, Cheng Z, Liu H, et al. Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients. Hepatology. 2017;65(5):1566–1580.
   PubMed Web of Science ®Google Scholar
• Hsieh JC, Kodjabachian L, Rebbert ML, et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature. 1999;398(6726):431–436.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Y, Xue J, et al. Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation. EMBO J. 2016;35(6):668–684.
   PubMed Web of Science ®Google Scholar
• Jung H-Y, Jun S, Lee M, et al. PAF and EZH2 induce Wnt/β-catenin signaling hyper activation. Mol Cell. 2013;52(2):193–205.
   PubMed Web of Science ®Google Scholar
• Zhang N, Wei P, Gong A, et al. FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011;20(4):427–442.
   PubMed Web of Science ®Google Scholar